Monomeric gp120 HIV-1 subtype C vaccine (Novartis Vaccines & Diagnostics)

N/A

Report date: 2024/01/02 20:03:52

Base Information

Drug NameMonomeric gp120 HIV-1 subtype C vaccine (Novartis Vaccines & Diagnostics)
Drug Alias NameBivalent subtype C gp120monomeric gp120 HIV-1 subtype C vaccine
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Genetically engineered subunit vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryZambiaTanzaniaSouth Africa
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma AgGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline PlcNovartis Vaccines
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A